Heartsciences Inc. (HSCS) Stock Price & Analysis
Heartsciences Inc. (HSCS) rose 2.17% to USD 1.88 as of June 10, 2026 at 03:35 UTC, according to Nexqual real-time market data.
HSCS last closed at USD 1.84; the session ranged USD 1.81–1.88 on volume of 11,126 shares. Market capitalization is $5.99M, with a 52-week range of USD 1.63–6.47 (NCM). Source: Nexqual, June 10, 2026 at 03:35 UTC.
Key Statistics (as of June 10, 2026 at 03:35 UTC)
| Price | USD 1.88 |
|---|---|
| Change | ▲ 2.17% (up) |
| Previous Close | USD 1.84 |
| Open | USD 1.86 |
| Day Range | USD 1.81 – 1.88 |
| 52-Week Range | USD 1.63 – 6.47 |
| Volume | 11,126 shares |
| Market Cap | $5.99M |
| Exchange | NCM |
Technical Analysis (HSCS)
Nexqual's technical model rates HSCS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:35 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.84 (neutral) |
| vs SMA50 | Below (USD 2.01) |
| MACD | -0.03 (negative) |
Analyst Ratings (HSCS)
Wall Street analysts rate HSCS "None" based on 2 analysts, with a mean price target of USD 10 (range USD 8–12), per Nexqual as of June 10, 2026 at 03:35 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 10 |
| High Target | USD 12 |
| Low Target | USD 8 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (HSCS)
| EPS Estimate | USD -0.67 |
|---|---|
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-01-31 | USD -0.63 vs est -0.88 ▲ beat |
| 2025-10-31 | USD -0.85 vs est -1.28 ▲ beat |
| 2025-07-31 | USD -1.58 vs est -1.88 ▲ beat |
| 2025-04-30 | USD -1.88 vs est -2.15 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:35 UTC.
Financials & Fundamentals (HSCS)
| Total Revenue | $8,669 |
|---|---|
| Gross Margin | +57.92% |
| Operating Margin | -89939.56% |
| Profit Margin | +0.00% |
| ROE | -382.32% |
| Debt / Equity | 145.81 |
| Current Ratio | 1.19 |
| Total Cash | $3.40M |
| Total Debt | $3.87M |
| Free Cash Flow | $-4.21M |
Source: Nexqual, June 10, 2026 at 03:35 UTC.
Financial Health Score (HSCS)
Nexqual rates Heartsciences Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:35 UTC.
| Growth | Critical — Revenue -77% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $3M cash vs $4M debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -382%, ROA -73.5% |
Ownership (HSCS)
| Insider Ownership | +2.34% |
|---|---|
| Institutional Ownership | +6.77% |
| Shares Outstanding | 3.18M |
| Float | 3.07M |
| Short % of Float | +1.40% |
Source: Nexqual, June 10, 2026 at 03:35 UTC.
Leadership (HSCS)
Heartsciences Inc. is led by Andrew Simpson (age 55), CEO, President & Chairman of the Board of Directors, per Nexqual as of June 10, 2026 at 03:35 UTC.
| CEO, President & Chairman of the Board of Directors | Andrew Simpson (age 55) |
|---|---|
| CFO & Treasurer | Danielle Watson (age 42) |
Major Backers & Investors (HSCS)
Notable institutional backers of Heartsciences Inc. include DRW Securities, LLC, TFB Advisors LLC, Fidelity, according to Nexqual as of June 10, 2026 at 03:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DRW Securities, LLC | 2.4% |
| TFB Advisors LLC | 0.93% |
| Fidelity | 0.76% |
| Astoria Strategic Wealth, Inc. | 0.59% |
| Tradition Wealth Management, LLC | 0.53% |
| UBS Group AG | 0.2% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.66% |
| Geode Capital | 0.91% |
Source: Nexqual, June 10, 2026 at 03:35 UTC.
From Heartsciences Inc.'s Latest SEC 10-K Filing (filed 2025-07-24)
Key Strengths & Strategy (as disclosed to the SEC)
- HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.94 | ▼ 1.02% |
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| ILAG | Intelligent Living Application | USD 3.73 | ▲ 6.57% |
| INBS | Intelligent Bio Solutions Inc. | USD 2.42 | ▼ 1.22% |
| TNON | Tenon Medical, Inc. | USD 0.62 | ▲ 2.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:35 UTC. This page is informational and not investment advice.